MKI67 and neoplasm: Consistent with the in vitro cell-proliferation assay data, the numbers of proliferating cells in the tumor masses increased significantly in tumors derived from shDsg2 cells, compared to those derived from control cells, as assessed by immunohistochemical staining with a Ki-67 antibody (Fig. 2c).